shares

Solar Growth and Market Transition: RMC Switchgears Shares Key Project and Listing Updates

JAIPUR, India, Sept. 23, 2025 /PRNewswire/ -- RMC Switchgears Limited (BSE: RMC) today shared an update on three key developments —…

3 days ago

CEA Industries Board Authorizes $250 Million Stock Buyback Program

NEW YORK, Sept. 19, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq: BNC), (“BNC” or the “Company”), the world’s leading…

5 days ago

Algernon Announces Preferred Share Class Approved at Annual and Special Meeting

VANCOUVER, British Columbia, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB:…

6 days ago

Aeluma Announces Proposed Public Offering of Common Stock

September 17, 2025 16:02 ET  | Source: Aeluma, Inc. GOLETA, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Aeluma, Inc. (NASDAQ:…

1 week ago

Intermap Technologies Files Final Short-Form Base Shelf Prospectus

Final Short-Form Base Shelf Prospectus Is accessible on SEDAR+ and EDGAR September 16, 2025 18:02 ET  | Source: Intermap Technologies…

1 week ago

Mobix Labs Files Form 425 With the SEC, Announces Intention to Launch Hostile Tender Offer for Peraso; Criticizes Recent Dilutive Financing and Efforts to Restrict Shareholder Communications

IRVINE, Calif.--(BUSINESS WIRE)--Mobix Labs, Inc. (NASDAQ: MOBX) (“Mobix Labs”) today announced that it has filed a Form 425 with the…

2 weeks ago

Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

September 12, 2025 16:30 ET  | Source: Fulcrum Therapeutics, Inc. CAMBRIDGE, Mass., Sept. 12, 2025 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics,…

2 weeks ago

Huawei Shares Industrial Challenges at the 2025 ICPC World Finals

BAKU, Azerbaijan, Sept. 10, 2025 /PRNewswire/ -- The St. Petersburg State University team has won the 2025 ICPC World Championship at the…

2 weeks ago

Athira Pharma Announces Reverse Stock Split

BOTHELL, Wash., Sept. 11, 2025 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (“Athira” or “Company”) (NASDAQ: ATHA), a clinical stage biopharmaceutical…

2 weeks ago